State Street Global Advisors, T. Rowe Price and Goldman Sachs have all updated their 2018 proxy voting policies.
The updated policy documents are available on the Governance Gateway to all CGIC members. A few of the amendments are noted below.
State Street Global Advisors reiterated their backing of ISG’s six corporate governance principles and expects that issuers comply or explain any deviations via direct engagement. They will evaluate poison pill proposals at Canadian companies on a case-by-case basis, looking at whether it conforms to a “new generation” rights plan. They will rely on engagement to examine Canadian companies’ compensation plans.
T. Rowe Price (which has switched from using Glass Lewis to ISS as their proxy advisor) stated they intend to focus on board diversity during engagement but will hold out (for now) on releasing new voting guidelines based on ethnic and gender board diversity. Their policy is to always vote against shareholders’ right to act by written consent, and “other business” proposals that lack specificity. When analysing pay-for-performance, T. Rowe Price nixed the use of Glass Lewis and Equilar’s outside research for assessing linkage between compensation and companies’ three-, four- and five-year incremental TSR.
GSAM’s updated US proxy voting guidelines included an amendment to vote against or withhold on certain directors or the lead director/chairman when average board tenure exceeds 15 years and there has not been a new nominee over the last five years.